UpLift Accelerates into Higher Ed with Acquisition of TAO Connect
UpLift Now Serves Over 170 Enterprise Customers Nationwide and Across Canada, Covering Over 4 Million People, Including Over 2 Million Students at More than 120 U.S. Higher Ed Institutions
Adds Therapy-Assisted Digital Programs and Resources to its Existing In-Network Care Platform Providing Therapy and Psychiatry
The lack of access to affordable behavioral healthcare is a key driver in America's mental health crisis. UpLift's integrated behavioral health platform helps patients match with the right team of providers based on their clinical and non-clinical needs, delivering next-day, in-network therapy and psychiatry through a national network of nearly 2000 licensed providers. With TAO by UpLift, a new behavioral health program for students, institutions now have access to a comprehensive higher ed mental healthcare solution, and the continuity of care designed to complement institutions' counseling service offerings, all covered by insurance.
Students desperately need access to affordable care. Key findings from the American College Health Association National College Health Assessment find that 77% of college students struggle with mental health and 53% did not receive care in the last 12 months. A recent survey, The College Student Behavioral Health Report, looked at the reasons students didn't seek care with the following findings: 51% "too expensive," 27% "couldn't find care," and 27% "wait times too long." Yet, 85% of college students have health insurance.
"We read about the crisis of care every day. College students are increasingly anxious, depressed, and struggling with loneliness and the pressure of academia, and institutions are proactively seeking ways to augment and complement their counseling services," said
Like UpLift, TAO Connect was conceived to fulfill the unmet need for more accessible and better mental healthcare treatment options and solutions, including telehealth. Although initially designed for higher ed, TAO Connect's evidence-based digital tools and resources have proved extendable and valuable to other enterprises, including large employers and health systems.
"Campus counseling services are improving and saving student's lives every day," said Dr.
TAO by UpLift is rolling out and activating across higher ed institutions in the country including and two- and four-year public and private schools and spanning community colleges, Historically Black Colleges and Universities (HBCUs), and graduate schools.
TAO Connect is a powerful tool for campuses committed to becoming health-promoting institutions, impacting students' lives every day," said
UpLift uses technology to enable a simple, personalized, equitable and accessible student experience. From navigation to treatment, students have 24/7 access to care, personalized provider recommendations and treatment, and a view of their progress through integrated measurement-based clinical assessments. With UpLift:
- New patients receive care within 1.4 days, on average
- 93% of patients with severe depression experienced a clinically meaningful reduction in symptoms
- 9 out of 10 patients say they feel better within 90 days
- 46% of providers identify as BIPOC
"UpLift's acquisition of TAO Connect will go a long way to servicing the higher ed market's unmet mental health needs, providing care continuity by adding team-based therapy and psychiatry, " said
UpLift was founded in partnership with Redesign Health, a healthcare innovation company. UpLift accepts insurance payments from most major commercial, Medicare and Medicaid health plans, including through agreements with national carriers UnitedHealthcare, Aetna and Cigna.
View original content:https://www.prnewswire.com/news-releases/uplift-accelerates-into-higher-ed-with-acquisition-of-tao-connect-302083520.html
SOURCE UpLift
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICAC Commissioner attends first IAACA European regional anti-corruption conference in Hungary
- Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NS
- Next Level Apparel x Got Sole Announce 2026 Partnership as Official Apparel Partner for U.S. Culture Festival Series
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share